Cyclerion Therapeutics Announces Strategic Agreement With Medsteer And Progress Toward Initiating Phase 2 Proof-Of-Concept Study For CYC-126 In Treatment-Resistant Depression January 6, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110558839/Cyclerion-Therapeutics-Announces-Strategic-Agreement-With-Medsteer-And-Progress-Toward-Initiating-Phase-2-Proof-Of-Concept-Study-For-CYC-126-In-Treatment-Resistant-Depression
